Guggenheim Capital’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Guggenheim Capital’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15,461	Closed	-$742K	–	1986
2020 Q1	$742K	Buy	15,461 +3,853	+33%	+$179K	0.01%	1222
2019 Q4	$545K	Buy	+11,608	New	+$513K	﹤0.01%	1560

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Guggenheim Capital's RARX Position: Q2 2020 in Review

Guggenheim Capital sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 15,461 shares — an estimated $742K sold.

Guggenheim Capital first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $742K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Guggenheim Capital reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Guggenheim Capital sold 15,461 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $742K.
Guggenheim Capital first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Guggenheim Capital's Ra Pharmaceuticals, Inc. Common Stock position peaked at $742K in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Guggenheim Capital's 13F filing for Q2 2020, filed 14 Aug 2020.